Skip to Main Content

Paper Details

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Mult Scler
14
2022
DMT, MS, Multiple Sclerosis, NMOSD, SARS-CoV-2, children, multiple sclerosis, neuromyelitis optica spectrum disorder, people, women
Author NameAffiliation
Marcin P MyckoUniversity of Warmia and Mazury in Olsztyn
David B CliffordWashington University in St. Louis
Xavier MontalbanIRCCS San Raffaele Scientific Institute, Italy/Vita-Salute San Raffaele University
Kathryn C FitzgeraldJohns Hopkins University
Bernhard HemmerTechnische Universitat Munchen
Bernhard HemmerTechnische Universitat Munchen
Fredrik PiehlKarolinska Institutet and Karolinska University Hospital
Krzysztof SelmajUniversity of Warmia and Mazury in Olsztyn
Per Soelberg SørensenCopenhagen University Hospital, Rigshospitalet
  • 1 - 9

Datasets

Release 1.2